advertisement

---

Huang T 6

Showing records 1 to 6 | Display all abstracts from Huang T

125703 A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)
Xiong X
BMC pharmacology & toxicology 2025; 26: 88

---

126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Li Q; Pan B
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659

---

125703 A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)
Zhang X
BMC pharmacology & toxicology 2025; 26: 88

---

126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Pan K
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659

---

125703 A real-world pharmacovigilance study of netarsudil based on the FDA adverse event reporting system (FAERS)
Tang F; Huang T
BMC pharmacology & toxicology 2025; 26: 88

---

126859 Enhanced ocular retention and intraocular pressure-lowering efficacy of hydrophobic microspheres for glaucoma treatment
Zhang Y; Rupenthal ID; Liu L; Hong Y; He L; Teng X; Yu X; Xiao Z; Huang J; Huang T; Shi Y; Rui W; Long Q; Hou D
Colloids and surfaces. B, Biointerfaces 2025; 252: 114659

---